Life Expectancy After Diagnosis of a Vestibular Schwannoma in Patients 70 Years and Older
- PMID: 37883070
- PMCID: PMC10603575
- DOI: 10.1001/jamaoto.2023.3485
Life Expectancy After Diagnosis of a Vestibular Schwannoma in Patients 70 Years and Older
Abstract
Importance: Over the past decades, the number of patients, especially in the older adult patient group, diagnosed with vestibular schwannoma (VS) has increased. Assuming that older adult patients have more comorbidities, a longer recovery period after surgery, a higher rate of surgical complications, and a higher mortality rate after VS surgery, a treatment strategy for this group of patients is warranted, based on clinical evidence on postsurgical survival.
Objective: To evaluate the survival after diagnosis of a VS in patients 70 years and older, treated with either observation or surgery, and to compare these findings with the life span of an age-matched background population in Denmark.
Design, setting, and participants: This was a retrospective cohort study of 624 patients 70 years and older diagnosed with VS in Denmark from 1976 to 2016. Since 1976, all patients with a VS have been registered in a national database, which contains 3637 patients. Of the included patients in this study, 477 were treated conservatively with the "wait-and-scan" strategy, and 147 were treated surgically with removal of the tumor. The survival of the patients was compared with a matched background population in Denmark. Data analysis was performed from January 1976 to January 2017.
Exposures: Surgery, radiotherapy, or none.
Main outcomes and measures: The main outcome was survival among the patients and compared with the matched background population.
Results: A total of 624 patients were included (317 female patients [50.8%] and 307 male patients [49.2%]). The mean (SD) survival in the observed patients was 9.2 (4.7) years after diagnosis, whereas for the background population, the expected survival was 11 years from the mean age at diagnosis. For the surgically treated patients, the mean (SD) survival was 11.8 (6.6) years, and expected survival was 11 years for the matched background population. The mean (SD) survival was 10.7 (5.5) years in female patients and 8.9 (5.0) years in male patients. There was no significant difference in survival between treatment modalities, irrespective of tumor size.
Conclusions and relevance: In this cohort study, survival after diagnosis of a VS in patients 70 years and older was similar in the surgical group compared with the age-matched background population. In the wait-and-scan group, the survival after diagnosis was marginally shorter, which may be associated with increased comorbidity.
Conflict of interest statement
Figures
Similar articles
-
Upfront Radiosurgery vs a Wait-and-Scan Approach for Small- or Medium-Sized Vestibular Schwannoma: The V-REX Randomized Clinical Trial.JAMA. 2023 Aug 1;330(5):421-431. doi: 10.1001/jama.2023.12222. JAMA. 2023. PMID: 37526718 Free PMC article. Clinical Trial.
-
A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.J Neurosurg. 2016 Dec;125(6):1472-1482. doi: 10.3171/2015.12.JNS151857. Epub 2016 Apr 1. J Neurosurg. 2016. PMID: 27035174
-
Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.Otol Neurotol. 2009 Oct;30(7):968-74. doi: 10.1097/MAO.0b013e3181b4e3c9. Otol Neurotol. 2009. PMID: 19730147
-
Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT.Southampton (UK): National Institute for Health and Care Research; 2022 Jun. Southampton (UK): National Institute for Health and Care Research; 2022 Jun. PMID: 35793425 Free Books & Documents. Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
